Durable Response of Low-Dose Afatinib plus Cetuximab in an Adenocarcinoma Patient with a Novel EGFR Exon 20 Insertion Mutation
2019 ◽
Vol 14
(10)
◽
pp. e220-e221
◽
2021 ◽
2020 ◽
Vol 12
◽
pp. 175883592093609
Keyword(s):
2019 ◽
Vol 14
(9)
◽
pp. e198-e200
◽
2019 ◽
Vol 14
(3)
◽
pp. e52-e54
◽
Keyword(s):